Increased tyrosine hydroxylase expression accompanied by glial changes within the non-lesioned hemisphere in the 6-hydroxydopamine model of Parkinson's disease-Reference-Cited by-同舟云学术

Increased tyrosine hydroxylase expression accompanied by glial changes within the non-lesioned hemisphere in the 6-hydroxydopamine model of Parkinson's disease

Published:2014 Issue:4 Volume:32 Page:447-462
ISSN:0922-6028
Container-title:Restorative Neurology and Neuroscience
language:
Short-container-title:

Author:

Schlachetzki Johannes C.M.¹,Marxreiter Franz¹²,Regensburger Martin²³,Kulinich Anna¹,Winner Beate³,Winkler Jürgen¹

Affiliation:

1. Department of Molecular Neurology, Friedrich-Alexander-Universität Erlangen-Nürnberg, University Hospital Erlangen, Erlangen, Germany

2. Department of Neurology, Friedrich-Alexander-Universität Erlangen-Nürnberg, University Hospital Erlangen, Erlangen, Germany

3. IZKF Junior Research Group III, Nikolaus-Fiebiger-Zentrum, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany

Publisher

IOS Press

Subject

Clinical Neurology,Developmental Neuroscience,Neurology

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CRISPR/sgRNA-directed synergistic activation mediator (SAM) as a therapeutic tool for Parkinson´s disease;Gene Therapy;2023-08-04

2. Gut microbial metabolites in Parkinson's disease: Association with lifestyle, disease characteristics, and treatment status;Neurobiology of Disease;2022-08

3. Parkinson's disease motor symptoms rescue by CRISPRa‐reprogramming astrocytes into GABAergic neurons;EMBO Molecular Medicine;2022-04-04

4. A review: traditional herbs and remedies impacting pathogenesis of Parkinson’s disease;Naunyn-Schmiedeberg's Archives of Pharmacology;2022-03-08

5. Aminochrome Induces Neuroinflammation and Dopaminergic Neuronal Loss: A New Preclinical Model to Find Anti-inflammatory and Neuroprotective Drugs for Parkinson’s Disease;Cellular and Molecular Neurobiology;2022-01-06